Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands

Open access
Ramos-Benítez, Marcos J., Ruiz-Jiménez, Caleb, Aguayo, Vasti, Espino, Ana M. · 2017 · Scientific Reports

Abstract

Recently, we reported that a native Fasciola hepatica fatty acid binding protein (FABP) termed Fh12 is a powerful anti-inflammatory protein capable of suppressing the LPS-induced expression of inflammatory markers in vivo and in vitro. Because the purification of a protein in native form is, in many situations not cost-beneficial and unsuitable for industrial grade scale-up, this study accomplished the task of optimizing the expression and purification of a recombinant form of FABP (Fh15). Additionally, we ascertained whether this molecule could exhibit a similar suppressive effect on TLR-stimulation and inflammatory cytokine expression from macrophages than those previously demonstrated for the native molecule. Results demonstrated that Fh15 suppresses the expression of IL-1β and TNFα in murine macrophages and THP1 Blue CD14 cells. Additionally, Fh15 suppress the LPS-induced TLR4 stimulation. This effect was not impaired by a thermal denaturing process or blocked by the presence of anti-Fh12 antibodies. Fh15 also suppressed the stimulation of various TLRs in response to whole bacteria extracts, suggesting that Fh15 could have a broad spectrum of action. These results support the possibility of using Fh15 as an excellent alternative for an anti-inflammatory drug in preclinical studies in the near future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-05735-w

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Optimization of the Fh15 expression in E. coli TOP10. cDNA encoding Fh15 was cloned into the pGEX-4T-2 and expressed in E. coli bacteria as a fusion protein with glutathione S-transferase (GST) of Schistosoma japonicum at the amino end of protein. Small-scale protein expression using 4-ml of LB medium was induced for 3 h at 27 °C, 225 rpm. (A) Bacteria lysates induced at various concentrations of IPTG were analyzed by 15% SDS-PAGE Coomassie blue stained. (B) Unstained gel was transferred to nitrocellulose membrane and incubated with specific anti-GST antibody labeled with peroxidase. Arrow indicates maximal expression of the GST-tagged protein estimated to be ~41–43 kDa, observed at 0.02 mM IPTG. (C) Fusion protein was purified from a large-scale expression culture using a GSTrap FF 5 ml column in an AKTA FPLC System. Fusion protein is eluted using the elution buffer (EB): 10 mM Tris-HCl pH 8.0 containing 10 mM GSH. (D) The purification process was analyzed by 15% SDS-PAGE. Lane-1: GST-Fh15 fusion protein, lane-2: GST-tag and lane-3: Fh15. Figure 1A,B and D represent cropped images from the original and are being displayed in black & white. Original full-length gels and blots are shown in Supplementary Figure 1.
Figure 1 Optimization of the Fh15 expression in E. coli TOP10. cDNA encoding Fh15 was cloned into the pGEX-4T-2 and expressed in E. coli bacteria as a fusion protein with glutathione S-transferase (GST) of Schistosoma japonicum at the amino end of protein. Small-scale protein expression using 4-ml of LB medium was induced for 3 h at 27 °C, 225 rpm. (A) Bacteria lysates induced at various concentrations of IPTG were analyzed by 15% SDS-PAGE Coomassie blue stained. (B) Unstained gel was transferred to nitrocellulose membrane and incubated with specific anti-GST antibody labeled with peroxidase. Arrow indicates maximal expression of the GST-tagged protein estimated to be ~41–43 kDa, observed at 0.02 mM IPTG. (C) Fusion protein was purified from a large-scale expression culture using a GSTrap FF 5 ml column in an AKTA FPLC System. Fusion protein is eluted using the elution buffer (EB): 10 mM Tris-HCl pH 8.0 containing 10 mM GSH. (D) The purification process was analyzed by 15% SDS-PAGE. Lane-1: GST-Fh15 fusion protein, lane-2: GST-tag and lane-3: Fh15. Figure 1A,B and D represent cropped images from the original and are being displayed in black & white. Original full-length gels and blots are shown in Supplementary Figure 1.CC BY · PubMed Central
Figure 2 Western blot and Inhibition ELISA analysis of purified Fh15 with anti-Fh12 or anti-ESP serum. Immunological identity between Fh15 and Fh12 was investigated. (A) Fh15 and Fh12 were analyzed by 15% SDS-PAGE, electrotransferred to nitrocellulose membranes and incubated with anti-Fh12 antibody (lanes 1 & 3) revealing a strong immunoreactive band of ~14.7 kDa, or incubated with anti-ESP antibody (lanes 2 & 4), respectively, revealing the band of ~14.7 kDa at weaker intensity. Figure 2A represents cropped images from the original. Original full-length gels and blots are shown in Supplementary Figure 1. In the Inhibition ELISA, the plate was coated with 15 μg/ml Fh12. Anti-Fh12 antibody (diluted 1:200) was mixed with increased amounts of Fh12 (B) or Fh15 (C) ranging from 2.5 to 40 μg/ml and after 1 h incubation at 37 °C was added to the plate. The secondary antibody was further added diluted 1:5000 followed by the substrate solution. Maximal inhibition values of ~43.5–48.5% were obtained at concentrations starting at 10 μg/ml protein, which is indicated on the figure with an arrow.
Figure 2 Western blot and Inhibition ELISA analysis of purified Fh15 with anti-Fh12 or anti-ESP serum. Immunological identity between Fh15 and Fh12 was investigated. (A) Fh15 and Fh12 were analyzed by 15% SDS-PAGE, electrotransferred to nitrocellulose membranes and incubated with anti-Fh12 antibody (lanes 1 & 3) revealing a strong immunoreactive band of ~14.7 kDa, or incubated with anti-ESP antibody (lanes 2 & 4), respectively, revealing the band of ~14.7 kDa at weaker intensity. Figure 2A represents cropped images from the original. Original full-length gels and blots are shown in Supplementary Figure 1. In the Inhibition ELISA, the plate was coated with 15 μg/ml Fh12. Anti-Fh12 antibody (diluted 1:200) was mixed with increased amounts of Fh12 (B) or Fh15 (C) ranging from 2.5 to 40 μg/ml and after 1 h incubation at 37 °C was added to the plate. The secondary antibody was further added diluted 1:5000 followed by the substrate solution. Maximal inhibition values of ~43.5–48.5% were obtained at concentrations starting at 10 μg/ml protein, which is indicated on the figure with an arrow.CC BY · PubMed Central
Figure 3 Immunoreactivity of Fh12 and Fh15 and Circular Dichroism spectra of Fh12 and Fh15 before and after a denaturing heat treatment. (A) Indirect ELISA was used to evaluate the immunoreactivity of Fh12 and Fh15 against the anti-Fh12 antibody diluted 1:200 in PBST before (Fh12 or Fh15) and after heat treatment (ΔFh12 or ΔFh15). No significant (n.s.) differences were found between the absorbance values of Fh12 and ΔFh12 or between Fh15 and ΔFh15. (B) CD spectra of Fh15 (solid line) and Fh12 (dashed line). Spectra was obtained at 25 °C using each protein at 0.1 mg/ml. (C) CD spectra of Fh15 and Fh12 after denaturing temperature treatment of 95 °C using each protein at 0.1 mg/ml.
Figure 3 Immunoreactivity of Fh12 and Fh15 and Circular Dichroism spectra of Fh12 and Fh15 before and after a denaturing heat treatment. (A) Indirect ELISA was used to evaluate the immunoreactivity of Fh12 and Fh15 against the anti-Fh12 antibody diluted 1:200 in PBST before (Fh12 or Fh15) and after heat treatment (ΔFh12 or ΔFh15). No significant (n.s.) differences were found between the absorbance values of Fh12 and ΔFh12 or between Fh15 and ΔFh15. (B) CD spectra of Fh15 (solid line) and Fh12 (dashed line). Spectra was obtained at 25 °C using each protein at 0.1 mg/ml. (C) CD spectra of Fh15 and Fh12 after denaturing temperature treatment of 95 °C using each protein at 0.1 mg/ml.CC BY · PubMed Central
Figure 4 Prediction of secondary and tertiary structures of Fh15. (A) Secondary structures of Fh15 predicted by the SOPMA and (B) tertiary structure of Fh15 predicted by Phyre2. Both programs are available at ExPASy server (Bioinformatics Resources Portal, www.expasy.org). Fh15 contains two short alpha helixes (h) and a large content of extended strands (e) and random coils (c). Amino acid residues into boxes (K21, K22, K83, K97, E100, E104 and D122) are predicted to bind to the LPS-binding pocket on the human CD14 structure according previous studies12.
Figure 4 Prediction of secondary and tertiary structures of Fh15. (A) Secondary structures of Fh15 predicted by the SOPMA and (B) tertiary structure of Fh15 predicted by Phyre2. Both programs are available at ExPASy server (Bioinformatics Resources Portal, www.expasy.org). Fh15 contains two short alpha helixes (h) and a large content of extended strands (e) and random coils (c). Amino acid residues into boxes (K21, K22, K83, K97, E100, E104 and D122) are predicted to bind to the LPS-binding pocket on the human CD14 structure according previous studies12.CC BY · PubMed Central
Figure 5 Effect of the heat treatment and the presence of anti-Fh12 antibodies on the capacity of Fh15 to suppress activation of different TLRs in THP1-Blue-CD14 cells. THP1 Blue-CD14 cells were seeded at 1 × 105 cells/well in 96-well flat-bottom plates. The levels of SEAP secreted to the culture media were estimated by reading at 655 nm, 18 h after TLR-ligand stimulation. (A) Cells were cultured with Fh15 (2.5 to 15 μg/ml) before stimulation with LPS (1 μg/ml). Fh15 significantly suppressed the LPS-induced TLR4-stimulation at concentrations of 5 μg/ml (**p = 0.0012), 10 μg/ml (***p = 0.001) and 15 μg/ml (****p < 0.0001). (B) Cells were first stimulated with LPS (1 μg/ml) and then exposed to Fh15 (10 μg/ml) 1, 3, 6 and 12 h after LPS-stimulation. After 18 h of LPS stimulation, the QB-reagent is added to culture and readings at 655 nm were done 4 h later. Fh15 significantly suppressed the induced LPS-TLR4 stimulation at all time points tested after LPS-stimulation. ***p = 0.0001, **p = 0.001. (C) The anti-Fh12 serum (endotoxin-free) at dilutions ranging among 1:5 to 1:400 was added in triplicate to culture followed of the addition of Fh15 (10 μg/ml) before stimulation with LPS (1 μg/ml). Fh15 significantly suppressed TLR-stimulation induced by LPS and the presence of high anti-Fh12 antibody concentration (1:5) make no difference (***p = 0.0001, ****p < 0.0001). (D) Cells cultured with untreated or heat denatured Fh15 (ΔFh15) for 10 min at 95 °C before stimulation with LPS (1 μg/ml), demonstrate strong suppression against LPS-TLR4 induced stimulation (****p < 0.0001). Differences between both Fh15 and ΔFh15 proteins were also observed (*p = 0.015).
Figure 5 Effect of the heat treatment and the presence of anti-Fh12 antibodies on the capacity of Fh15 to suppress activation of different TLRs in THP1-Blue-CD14 cells. THP1 Blue-CD14 cells were seeded at 1 × 105 cells/well in 96-well flat-bottom plates. The levels of SEAP secreted to the culture media were estimated by reading at 655 nm, 18 h after TLR-ligand stimulation. (A) Cells were cultured with Fh15 (2.5 to 15 μg/ml) before stimulation with LPS (1 μg/ml). Fh15 significantly suppressed the LPS-induced TLR4-stimulation at concentrations of 5 μg/ml (**p = 0.0012), 10 μg/ml (***p = 0.001) and 15 μg/ml (****p < 0.0001). (B) Cells were first stimulated with LPS (1 μg/ml) and then exposed to Fh15 (10 μg/ml) 1, 3, 6 and 12 h after LPS-stimulation. After 18 h of LPS stimulation, the QB-reagent is added to culture and readings at 655 nm were done 4 h later. Fh15 significantly suppressed the induced LPS-TLR4 stimulation at all time points tested after LPS-stimulation. ***p = 0.0001, **p = 0.001. (C) The anti-Fh12 serum (endotoxin-free) at dilutions ranging among 1:5 to 1:400 was added in triplicate to culture followed of the addition of Fh15 (10 μg/ml) before stimulation with LPS (1 μg/ml). Fh15 significantly suppressed TLR-stimulation induced by LPS and the presence of high anti-Fh12 antibody concentration (1:5) make no difference (***p = 0.0001, ****p < 0.0001). (D) Cells cultured with untreated or heat denatured Fh15 (ΔFh15) for 10 min at 95 °C before stimulation with LPS (1 μg/ml), demonstrate strong suppression against LPS-TLR4 induced stimulation (****p < 0.0001). Differences between both Fh15 and ΔFh15 proteins were also observed (*p = 0.015).CC BY · PubMed Central
Figure 6 Fh15 suppresses the stimulation of multiple toll-like receptors. (A) THP1 Blue-CD14 cells were seeded at 1 × 105 cells/well in 96-well flat-bottom plates and cultured with Fh15 (10 μg/ml) alone or 30 min prior to stimulation with optimized concentrations (established by the manufacturer) of heat killed Listeria monocytogenes (HKLM; 108 cells/ml), flagellin (FLA; 1 μg/ml) or ortozialoquinoline (CL075; 10 μg/ml). Control cells were stimulated with PBS or a single TLR-ligand. (B) Cells were cultured with Fh15 (10 μg/ml) and then stimulated with whole extracts (1 × 108 cells/ml) of Enterococcus faecalis or Klebsiella pneumonia. Cells incubated only with each bacteria extract were used as activation control. Fh15 significantly suppressed (****p < 0.0001) the stimulation induced by all TLR-ligands or whole bacteria extracts.
Figure 6 Fh15 suppresses the stimulation of multiple toll-like receptors. (A) THP1 Blue-CD14 cells were seeded at 1 × 105 cells/well in 96-well flat-bottom plates and cultured with Fh15 (10 μg/ml) alone or 30 min prior to stimulation with optimized concentrations (established by the manufacturer) of heat killed Listeria monocytogenes (HKLM; 108 cells/ml), flagellin (FLA; 1 μg/ml) or ortozialoquinoline (CL075; 10 μg/ml). Control cells were stimulated with PBS or a single TLR-ligand. (B) Cells were cultured with Fh15 (10 μg/ml) and then stimulated with whole extracts (1 × 108 cells/ml) of Enterococcus faecalis or Klebsiella pneumonia. Cells incubated only with each bacteria extract were used as activation control. Fh15 significantly suppressed (****p < 0.0001) the stimulation induced by all TLR-ligands or whole bacteria extracts.CC BY · PubMed Central
Figure 7 Fh15 suppressed the expression of TNFα and IL1β cytokines from mouse BMDM and human monocyte cell line (THP1-Blue CD14) in response to LPS. Bone marrow derived macrophages (BMDM) from naive C57BL/6 mice and THP1-Blue CD14 cells were treated with 5 μg/ml or 10 μg/ml Fh15, respectively 30 min before stimulation with LPS (100ng/ml or 1 μg/ml, respectively). Control cells were treated with LPS or PBS alone. After treatments cells were incubated by 18 h, at 37 °C 5% CO2. Expression of IL-1β and TNFα was measured by real-time RT-PCR. Results shown are expressed as fold-changes in expression relative to cells stimulated with PBS and presented as mean ± SD of a minimum of three experiments, each in triplicate. (A and C) Fh15 significantly suppressed the expression of IL-1β and TNFα and IL-1β in murine BMDM (**p < 0.01 and ***p < 0.001), respectively. (B and D) Fh15 also significantly suppressed the expression of IL-1β and TNFα in THP1 Blue-CD14 cells.
Figure 7 Fh15 suppressed the expression of TNFα and IL1β cytokines from mouse BMDM and human monocyte cell line (THP1-Blue CD14) in response to LPS. Bone marrow derived macrophages (BMDM) from naive C57BL/6 mice and THP1-Blue CD14 cells were treated with 5 μg/ml or 10 μg/ml Fh15, respectively 30 min before stimulation with LPS (100ng/ml or 1 μg/ml, respectively). Control cells were treated with LPS or PBS alone. After treatments cells were incubated by 18 h, at 37 °C 5% CO2. Expression of IL-1β and TNFα was measured by real-time RT-PCR. Results shown are expressed as fold-changes in expression relative to cells stimulated with PBS and presented as mean ± SD of a minimum of three experiments, each in triplicate. (A and C) Fh15 significantly suppressed the expression of IL-1β and TNFα and IL-1β in murine BMDM (**p < 0.01 and ***p < 0.001), respectively. (B and D) Fh15 also significantly suppressed the expression of IL-1β and TNFα in THP1 Blue-CD14 cells.CC BY · PubMed Central
Figure 8 Cell viability. Mouse BMDM and THP1-Blue CD14 cells were exposed to Fh15, LPS or Fh15 + LPS during 12 or 24 h. Cell viability was determined by adding 50 μl XTT to each well. After an additional incubation of 24 h at 37 °C the absorbance of each well was read at 480 nm.
Figure 8 Cell viability. Mouse BMDM and THP1-Blue CD14 cells were exposed to Fh15, LPS or Fh15 + LPS during 12 or 24 h. Cell viability was determined by adding 50 μl XTT to each well. After an additional incubation of 24 h at 37 °C the absorbance of each well was read at 480 nm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 41

Metadata

Authors
Ramos-Benítez, M. J., Ruiz-Jiménez, C., Aguayo, V., & Espino, A. M.
Affiliations
University of Puerto Rico, Medical Sciences Campus (PR)
Corresponding author
Espino, Ana M.
Venue
Scientific Reports
Published
2017-07-14
Volume
7
Issue
1
Pages
5455-5455
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2735574704
Cited by
41
References
55
Citations by year
2026: 1 · 2025: 6 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 11 · 2020: 2 · 2019: 2 · 2018: 3
FWCI
0.87
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (G12-MD007600, P40OD012217)
  • National Institute of General Medical Sciences (R25GM061838)
  • National Institute on Minority Health and Health Disparities (G12MD007600)
  • Office of Research Infrastructure Programs, National Institutes of Health (2-P40- OD012217)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Life Sciences › Immunology and Microbiology › Parasitology › Helminth infection and control
Keywords
Fasciola hepatica, fatty acid binding protein, recombinant protein expression, anti-inflammatory proteins, TLR4, lipopolysaccharide, macrophages, IL-1β, TNF-α, bacterial ligands, anti-inflammatory agents
MeSH terms
Protein Conformation, alpha-Helical, Protein Conformation, beta-Strand, THP-1 Cells, Animals, Anti-Inflammatory Agents, Non-Steroidal, Cloning, Molecular, Escherichia coli, Fasciola hepatica, Female, Humans, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Models, Molecular, Recombinant Fusion Proteins, Tumor Necrosis Factor-alpha, Helminth Proteins, Gene Expression, Protein Structure, Tertiary, Fatty Acid-Binding Proteins, Toll-Like Receptor 4, Mice, Interleukin-1beta, Antibodies, Neutralizing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands. https://app.cochat.ai/papers/10.1038/s41598-017-05735-w
The paper
Ramos-Benítez, M. J., Ruiz-Jiménez, C., Aguayo, V., & Espino, A. M. (2017). Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands. Scientific Reports. https://doi.org/10.1038/s41598-017-05735-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.